1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by mRNA Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Vaccine 1.4.3 Drugs 1.5 Market by Application 1.5.1 Global mRNA Therapy Market Share by Application: 2020 VS 2026 1.5.2 mRNA Targeted Delivery in vivo 1.5.3 Genetically Modified T cells 1.5.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer 1.5.5 Small Molecule Drugs Discovery 1.6 Coronavirus Disease 2019 (Covid-19): mRNA Therapy Industry Impact 1.6.1 How the Covid-19 is Affecting the mRNA Therapy Industry 1.6.1.1 mRNA Therapy Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and mRNA Therapy Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for mRNA Therapy Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 mRNA Therapy Market Perspective (2015-2026) 2.2 mRNA Therapy Growth Trends by Regions 2.2.1 mRNA Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 mRNA Therapy Historic Market Share by Regions (2015-2020) 2.2.3 mRNA Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 mRNA Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key mRNA Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top mRNA Therapy Players by Market Size 3.1.1 Global Top mRNA Therapy Players by Revenue (2015-2020) 3.1.2 Global mRNA Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global mRNA Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global mRNA Therapy Market Concentration Ratio 3.2.1 Global mRNA Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by mRNA Therapy Revenue in 2019 3.3 mRNA Therapy Key Players Head office and Area Served 3.4 Key Players mRNA Therapy Product Solution and Service 3.5 Date of Enter into mRNA Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global mRNA Therapy Historic Market Size by Type (2015-2020) 4.2 Global mRNA Therapy Forecasted Market Size by Type (2021-2026) 5 mRNA Therapy Breakdown Data by Application (2015-2026) 5.1 Global mRNA Therapy Market Size by Application (2015-2020) 5.2 Global mRNA Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America mRNA Therapy Market Size (2015-2020) 6.2 mRNA Therapy Key Players in North America (2019-2020) 6.3 North America mRNA Therapy Market Size by Type (2015-2020) 6.4 North America mRNA Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe mRNA Therapy Market Size (2015-2020) 7.2 mRNA Therapy Key Players in Europe (2019-2020) 7.3 Europe mRNA Therapy Market Size by Type (2015-2020) 7.4 Europe mRNA Therapy Market Size by Application (2015-2020) 8 China 8.1 China mRNA Therapy Market Size (2015-2020) 8.2 mRNA Therapy Key Players in China (2019-2020) 8.3 China mRNA Therapy Market Size by Type (2015-2020) 8.4 China mRNA Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan mRNA Therapy Market Size (2015-2020) 9.2 mRNA Therapy Key Players in Japan (2019-2020) 9.3 Japan mRNA Therapy Market Size by Type (2015-2020) 9.4 Japan mRNA Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia mRNA Therapy Market Size (2015-2020) 10.2 mRNA Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia mRNA Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia mRNA Therapy Market Size by Application (2015-2020) 11 India 11.1 India mRNA Therapy Market Size (2015-2020) 11.2 mRNA Therapy Key Players in India (2019-2020) 11.3 India mRNA Therapy Market Size by Type (2015-2020) 11.4 India mRNA Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America mRNA Therapy Market Size (2015-2020) 12.2 mRNA Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America mRNA Therapy Market Size by Type (2015-2020) 12.4 Central & South America mRNA Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Moderna 13.1.1 Moderna Company Details 13.1.2 Moderna Business Overview and Its Total Revenue 13.1.3 Moderna mRNA Therapy Introduction 13.1.4 Moderna Revenue in mRNA Therapy Business (2015-2020)) 13.1.5 Moderna Recent Development 13.2 BioNTech 13.2.1 BioNTech Company Details 13.2.2 BioNTech Business Overview and Its Total Revenue 13.2.3 BioNTech mRNA Therapy Introduction 13.2.4 BioNTech Revenue in mRNA Therapy Business (2015-2020) 13.2.5 BioNTech Recent Development 13.3 Pfizer 13.3.1 Pfizer Company Details 13.3.2 Pfizer Business Overview and Its Total Revenue 13.3.3 Pfizer mRNA Therapy Introduction 13.3.4 Pfizer Revenue in mRNA Therapy Business (2015-2020) 13.3.5 Pfizer Recent Development 13.4 Arcturus Therapeutics Holdings Inc. 13.4.1 Arcturus Therapeutics Holdings Inc. Company Details 13.4.2 Arcturus Therapeutics Holdings Inc. Business Overview and Its Total Revenue 13.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Introduction 13.4.4 Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2015-2020) 13.4.5 Arcturus Therapeutics Holdings Inc. Recent Development 13.5 Astrazeneca 13.5.1 Astrazeneca Company Details 13.5.2 Astrazeneca Business Overview and Its Total Revenue 13.5.3 Astrazeneca mRNA Therapy Introduction 13.5.4 Astrazeneca Revenue in mRNA Therapy Business (2015-2020) 13.5.5 Astrazeneca Recent Development 13.6 CureVac 13.6.1 CureVac Company Details 13.6.2 CureVac Business Overview and Its Total Revenue 13.6.3 CureVac mRNA Therapy Introduction 13.6.4 CureVac Revenue in mRNA Therapy Business (2015-2020) 13.6.5 CureVac Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. mRNA Therapy Key Market Segments Table 2. Key Players Covered: Ranking by mRNA Therapy Revenue Table 3. Ranking of Global Top mRNA Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Vaccine Table 6. Key Players of Drugs Table 7. COVID-19 Impact Global Market: (Four mRNA Therapy Market Size Forecast Scenarios) Table 8. Opportunities and Trends for mRNA Therapy Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for mRNA Therapy Players to Combat Covid-19 Impact Table 12. Global mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global mRNA Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global mRNA Therapy Market Size by Regions (2015-2020) (US$ Million) Table 15. Global mRNA Therapy Market Share by Regions (2015-2020) Table 16. Global mRNA Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global mRNA Therapy Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. mRNA Therapy Market Growth Strategy Table 22. Main Points Interviewed from Key mRNA Therapy Players Table 23. Global mRNA Therapy Revenue by Players (2015-2020) (Million US$) Table 24. Global mRNA Therapy Market Share by Players (2015-2020) Table 25. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Therapy as of 2019) Table 26. Global mRNA Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players mRNA Therapy Product Solution and Service Table 29. Date of Enter into mRNA Therapy Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 32. Global mRNA Therapy Market Size Share by Type (2015-2020) Table 33. Global mRNA Therapy Revenue Market Share by Type (2021-2026) Table 34. Global mRNA Therapy Market Size Share by Application (2015-2020) Table 35. Global mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 36. Global mRNA Therapy Market Size Share by Application (2021-2026) Table 37. North America Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 38. North America Key Players mRNA Therapy Market Share (2019-2020) Table 39. North America mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 40. North America mRNA Therapy Market Share by Type (2015-2020) Table 41. North America mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 42. North America mRNA Therapy Market Share by Application (2015-2020) Table 43. Europe Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 44. Europe Key Players mRNA Therapy Market Share (2019-2020) Table 45. Europe mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 46. Europe mRNA Therapy Market Share by Type (2015-2020) Table 47. Europe mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 48. Europe mRNA Therapy Market Share by Application (2015-2020) Table 49. China Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 50. China Key Players mRNA Therapy Market Share (2019-2020) Table 51. China mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 52. China mRNA Therapy Market Share by Type (2015-2020) Table 53. China mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 54. China mRNA Therapy Market Share by Application (2015-2020) Table 55. Japan Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 56. Japan Key Players mRNA Therapy Market Share (2019-2020) Table 57. Japan mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 58. Japan mRNA Therapy Market Share by Type (2015-2020) Table 59. Japan mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 60. Japan mRNA Therapy Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players mRNA Therapy Market Share (2019-2020) Table 63. Southeast Asia mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia mRNA Therapy Market Share by Type (2015-2020) Table 65. Southeast Asia mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia mRNA Therapy Market Share by Application (2015-2020) Table 67. India Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 68. India Key Players mRNA Therapy Market Share (2019-2020) Table 69. India mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 70. India mRNA Therapy Market Share by Type (2015-2020) Table 71. India mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 72. India mRNA Therapy Market Share by Application (2015-2020) Table 73. Central & South America Key Players mRNA Therapy Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players mRNA Therapy Market Share (2019-2020) Table 75. Central & South America mRNA Therapy Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America mRNA Therapy Market Share by Type (2015-2020) Table 77. Central & South America mRNA Therapy Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America mRNA Therapy Market Share by Application (2015-2020) Table 79. Moderna Company Details Table 80. Moderna Business Overview Table 81. Moderna Product Table 82. Moderna Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 83. Moderna Recent Development Table 84. BioNTech Company Details Table 85. BioNTech Business Overview Table 86. BioNTech Product Table 87. BioNTech Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 88. BioNTech Recent Development Table 89. Pfizer Company Details Table 90. Pfizer Business Overview Table 91. Pfizer Product Table 92. Pfizer Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 93. Pfizer Recent Development Table 94. Arcturus Therapeutics Holdings Inc. Company Details Table 95. Arcturus Therapeutics Holdings Inc. Business Overview Table 96. Arcturus Therapeutics Holdings Inc. Product Table 97. Arcturus Therapeutics Holdings Inc. Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 98. Arcturus Therapeutics Holdings Inc. Recent Development Table 99. Astrazeneca Company Details Table 100. Astrazeneca Business Overview Table 101. Astrazeneca Product Table 102. Astrazeneca Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 103. Astrazeneca Recent Development Table 104. CureVac Company Details Table 105. CureVac Business Overview Table 106. CureVac Product Table 107. CureVac Revenue in mRNA Therapy Business (2015-2020) (Million US$) Table 108. CureVac Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global mRNA Therapy Market Share by Type: 2020 VS 2026 Figure 2. Vaccine Features Figure 3. Drugs Features Figure 4. Global mRNA Therapy Market Share by Application: 2020 VS 2026 Figure 5. mRNA Targeted Delivery in vivo Case Studies Figure 6. Genetically Modified T cells Case Studies Figure 7. Transforming Nanoparticles to Develop Immunotherapy for Cancer Case Studies Figure 8. Small Molecule Drugs Discovery Case Studies Figure 9. mRNA Therapy Report Years Considered Figure 10. Global mRNA Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global mRNA Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global mRNA Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global mRNA Therapy Market Share by Players in 2019 Figure 15. Global Top mRNA Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by mRNA Therapy Revenue in 2019 Figure 17. North America mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America mRNA Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Moderna Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Moderna Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 26. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. BioNTech Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 28. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Pfizer Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 30. Arcturus Therapeutics Holdings Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Arcturus Therapeutics Holdings Inc. Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 32. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Astrazeneca Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 34. CureVac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. CureVac Revenue Growth Rate in mRNA Therapy Business (2015-2020) Figure 36. Bottom-up and Top-down Approaches for This Report Figure 37. Data Triangulation Figure 38. Key Executives Interviewed

Moderna BioNTech Pfizer Arcturus Therapeutics Holdings Inc. Astrazeneca CureVac